AP1867-2-(carboxymethoxy)

Target: This ligand targets FK506-binding protein FKBP12 in biochemical or cellular target-engagement studies.

Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for FK506-binding protein FKBP12. In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings FK506-binding protein FKBP12 into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.

• PROTAC-Mediated Target Degradation: AP1867-2-(carboxymethoxy) can serve as a ligand component in PROTAC constructs to recruit an E3 ligase and drive ubiquitination of a chosen target protein. This enables selective degradation rather than inhibition, supporting mechanistic studies of target turnover, pathway rewiring, and degradation kinetics across cellular models.

• E3 Ligase Recruitment Optimization: The carboxymethoxy functionality can be leveraged to tune linker attachment geometry and physicochemical properties in PROTAC designs. Researchers can systematically vary conjugation position and linker length to maximize productive ternary complex formation, improving degradation potency and selectivity while minimizing off-target ubiquitination.

• Ternary Complex and Binding Studies: AP1867-2-(carboxymethoxy)–based PROTACs are suitable for investigating the formation and stability of target–PROTAC–E3 ligase ternary complexes. Quantitative binding and biophysical assays can correlate ternary engagement with degradation efficiency, clarifying structure–activity relationships and informing rational PROTAC optimization.

• Mechanistic Ubiquitin-Proteasome Profiling: Using AP1867-2-(carboxymethoxy) in PROTAC experiments allows probing whether degradation proceeds through the ubiquitin–proteasome pathway. Researchers can apply proteasome inhibition, ubiquitination readouts, and time-resolved protein turnover measurements to distinguish degradation mechanisms and define critical steps in the catalytic degradation cycle.

AP1867-2-(carboxymethoxy) is a FKBP-family ligand intended for use as the target-engaging component or reference ligand in PROTAC discovery workflows. Its known small-molecule recognition profile enables rational linker-vector evaluation and comparative degrader design. This molecule is described in detail below.

Structure: The structure of AP1867-2-(carboxymethoxy) is characterized by carboxylic acid or carboxylate handle; primary or secondary amine/basic nitrogen centers. These features provide defined hydrogen-bonding, hydrophobic, and steric elements that can support affinity retention while enabling analogue-based linker-vector selection.

Reactivity: The acid handle supports amide coupling with amino-PEG, alkyl-diamine, piperazine, or aminoalkyl E3-ligase ligands. For FKBP-directed chemical biology, it may be connected to degradation or dimerization modules through flexible PEG/alkyl or amide-containing linkers, subject to FKBP-binding SAR. In practice, incorporation into PROTACs should begin from derivatives that preserve the reported binding pharmacophore, followed by systematic variation of linker length, polarity, rigidity, and exit-vector geometry to optimize target engagement, E3 recruitment, and cellular degradation readouts.